Literature DB >> 17092455

Occurrence of and mortality from childhood neuronal ceroid lipofuscinoses in norway.

Liv Berit Augestad1, William Dana Flanders.   

Abstract

The aim of this study was to estimate the prevalence of, incidence of, and survival from childhood neuronal lipofuscinoses in Norway. All children with neuronal ceroid lipofuscinoses living in Norway are referred to the Tambartun National Resource Centre for the Visually Impaired. We based the data collection on the medical records at Tambartun. We identified 70 children with neuronal ceroid lipofuscinoses who were born in Norway from 1957 to 1998. Seven had a diagnosis of late infantile neuronal ceroid lipofuscinoses, and 63 had the juvenile form of neuronal ceroid lipofuscinoses. In 2005, the prevalence of childhood neuronal ceroid lipofuscinoses was 8.3 per million inhabitants in Norway, and all children were diagnosed with the juvenile form. The average annual incidence rate of childhood neuronal ceroid lipofuscinoses was 1.8 per 100,000 live births using the years from 1957 to 1978 and 3.9 using the years from 1978 to 1999. The trend in incidence increased at an annual rate of about 3.3% per year (P = .001), averaged over this period. Restricted to the most recent period (1967-1998), the trend was much weaker (1.4% increase per year; P = .3), and confidence intervals included the possibility of no trend. The median age at death of children diagnosed with late infantile neuronal ceroid lipofuscinoses was 12 years (95% confidence interval 9-14) and 26 years (95% confidence interval 25-30) for children diagnosed with the juvenile form. The results did not support the hypothesis that children with neuronal ceroid lipofuscinoses born in 1975 or later lived longer than those born from 1957 to 1975 (relative risk 1.0, 95% confidence interval 0.36-2.8). Mortality was similar for both genders (hazard ratio 0.97, 95% confidence interval 0.4-2.2).

Entities:  

Mesh:

Year:  2006        PMID: 17092455     DOI: 10.1177/08830738060210110801

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis.

Authors:  David E Sleat; Erika Gedvilaite; Yeting Zhang; Peter Lobel; Jinchuan Xing
Journal:  Gene       Date:  2016-08-20       Impact factor: 3.688

Review 2.  Clinical aspects of neuropathic lysosomal storage disorders.

Authors:  Laura Bannach Jardim; Maria Mercedes Villanueva; Carolina F Moura de Souza; Cristina B Oliveira Netto
Journal:  J Inherit Metab Dis       Date:  2010-05-21       Impact factor: 4.982

3.  Proteolytic processing of the neuronal ceroid lipofuscinosis related lysosomal protein CLN5.

Authors:  Bhagya De Silva; Jessie Adams; Stella Y Lee
Journal:  Exp Cell Res       Date:  2015-09-03       Impact factor: 3.905

Review 4.  Current Discoveries and Interventions for Barlow's Disease.

Authors:  Juan A Siordia
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

5.  Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures.

Authors:  Myriam Abdennadher; Sara Inati; Ariane Soldatos; Gina Norato; Eva H Baker; Audrey Thurm; Luca Bartolini; Ruturaj Masvekar; William Theodore; Bibiana Bielekova; Forbes D Porter; An N Dang Do
Journal:  J Inherit Metab Dis       Date:  2021-02-15       Impact factor: 4.750

Review 6.  Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview.

Authors:  Alessandro Simonati; Ruth E Williams
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

7.  Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy.

Authors:  Filippo Maria Santorelli; Barbara Garavaglia; Francesco Cardona; Nardo Nardocci; Bernardo Dalla Bernardina; Stefano Sartori; Agnese Suppiej; Enrico Bertini; Dianela Claps; Roberta Battini; Roberta Biancheri; Mirella Filocamo; Francesco Pezzini; Alessandro Simonati
Journal:  Orphanet J Rare Dis       Date:  2013-02-02       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.